Skip to main content

Table 1 Patient characteristics

From: Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

  

No. patients

%

Total no. of patients

 

18

 

Age, years

   

Median (range)

 

67 (57-69)

 

ECOG PS

   
 

0

18

100

Serum PSA, ng/mL

   

Median (range)

 

25.8 (5.1-45.1)

 

Clinical stage, T

   
 

1

3

18.8

 

2

6

37.5

 

3

6

37.5

 

4

1

6.3

Gleason score

   
 

5

1

6.3

 

6

1

6.3

 

7

3

18.8

 

8

1

6.3

 

9

7

43.8

 

10

3

18.8